Skip to content
In deliveryUnited KingdomGoodsFramework agreement£877,670,570

NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026

Awarded to ACCORD-UK LTD, AMGEN LIMITED, AVENTIS PHARMA LIMITED t-a Sanofi +22 more

NHS England(buyer)

Published
Published 22 May 2025
Deadline
Closed 17 April 2026

Tender documents

Skim pulls every file the buyer attaches to this process and extracts the requirements from it.

Documents as they publish

Specification, evaluation criteria, pricing schedules and every requirement — extracted, searchable and mapped to your response.

View tender files

Overview

NHS England has awarded a branded medicines framework agreement across multiple lots to 25 pharmaceutical suppliers, with a total contract value of £1.4 billion. Lot 1 covers Tranche A medicines for the North of England and Midlands & East from September 2026 to August 2028 (with a 24-month extension option), while Lot 2 supplies Natalizumab for London and South of England from September 2026 to August 2027 (with a 12-month extension option).

Contracting authority

Find the key decision makers

The people who scope, score and sign this contract — names, roles and how to reach them.

Lots (2)

  • CM/PHR/25/5730/01 - Tranche B for NOFE and MAE

    Lot 1 - Tranche A for the North of England and Midlands & East. Period of Framework Agreement: 1st September 2026 to 31st August 2028 with an option or option(s) to extend (at the authority’s discretion for a further 24 months.

    £665,389,588Won by ACCORD-UK LTDWon by AMGEN LIMITEDWon by AVENTIS PHARMA LIMITED t-a SanofiWon by BAYER PLCWon by BIOGEN IDEC LIMITEDWon by CHUGAI PHARMA LIMITEDWon by CST PHARMA LIMITEDWon by ELI LILLY & COMPANY LTDWon by GEDEON RICHTER (UK) LIMITEDWon by GLAXOSMITHKLINE UK LIMITEDWon by LABORATORIES JUVISE PHARMACEUTICALSWon by MERCK SERONO LIMITEDWon by MILPHARM LIMITEDWon by NAPP PHARMACEUTICALS LTDWon by NOVO NORDISKWon by ORIFARM UK LTDWon by PFIZER LIMITEDWon by PHARMACOSMOS UK LTDWon by ROCHE PRODUCTS LIMITEDWon by SANDOZ LIMITEDWon by TEVA UK LIMITEDWon by THORNTON & ROSS LIMITEDWon by VIATRIS UK HEALTHCARE LTDWon by VIFOR PHARMA UK LTDWon by BAYER PLCWon by CIPLA (EU) LIMITEDWon by NOVO NORDISK
  • CM/PHR/25/5730/02 - Natalizumab for London & SOFE

    Lot 2 - Natalizumab for London and South of England. The period of Framework Agreement : 1st September 2026 to 31st August 2027 with an option or option(s) to extend for a further 12 months.

    £35,312,548Won by BIOGEN IDEC LIMITEDWon by SANDOZ LIMITED

Key details

Country
United Kingdom
Status
In delivery
Category
Goods
Estimated value
£877,670,570
Procedure
Open
Contract type
Framework agreement
SME suitable
Yes
Published
22 May 2025
Questions by
10 April 2026
Deadline
Closed
Classification (CPV)
Pharmaceutical products

Award outcome

Awarded value
£1,401,404,272
Award date
14 June 2026
Contract period
31 August 2026 → 31 August 2028
Winners
  • ACCORD-UK LTD
  • AMGEN LIMITED
  • AVENTIS PHARMA LIMITED t-a Sanofi
  • BAYER PLC
  • BIOGEN IDEC LIMITED
  • CHUGAI PHARMA LIMITED
  • CIPLA (EU) LIMITED
  • CST PHARMA LIMITED
  • ELI LILLY & COMPANY LTD
  • GEDEON RICHTER (UK) LIMITED
  • GLAXOSMITHKLINE UK LIMITED
  • LABORATORIES JUVISE PHARMACEUTICALS
  • MERCK SERONO LIMITED
  • MILPHARM LIMITED
  • NAPP PHARMACEUTICALS LTD
  • NOVO NORDISK
  • ORIFARM UK LTD
  • PFIZER LIMITED
  • PHARMACOSMOS UK LTD
  • ROCHE PRODUCTS LIMITED
  • SANDOZ LIMITED
  • TEVA UK LIMITED
  • THORNTON & ROSS LIMITED
  • VIATRIS UK HEALTHCARE LTD
  • VIFOR PHARMA UK LTD

Contract ending soon? Skim tracks incumbents and flags recompetes early. Start for Free to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract

    21 July 2026

  2. Award Update · Contract Update

    9 July 2026

  3. Contract

    23 June 2026

  4. Contract Notice

    17 March 2026

  5. Planning Update

    13 March 2026

  6. Prior Information Notice

    13 January 2026

  7. Planning Update

    3 June 2025

  8. Prior Information Notice

    22 May 2025

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

How to win this tender

Skim reads the notice and every document attached to it, scores the fit against your company profile for a clear bid or no-bid call, then drafts each answer from your own evidence and past bids. You review, refine and submit — on time, with every requirement covered.

See exactly how Skim’s agents do this →

Comparing platforms? Skim is set against the alternatives for pre-tender intelligence, tender management software and bid management software.

Find tenders like this before your competitors do.

Skim scans every portal daily and scores each tender against your profile. Start for free and see the tenders you are missing.